Clintex CTiHow CTAi fits an evolving Clinical Trials marketThe global AI in clinical trials market is estimated to be worth $ 2.04 billion in 2024 and expected to grow at compounded annual growth…3 min read·Feb 6, 2024--1--1
Clintex CTiClinTex x DeSciThe scientific landscape is on the cusp of a paradigm shift. Enter Decentralised Science (DeSci), a revolutionary approach that leverages…3 min read·Jan 19, 2024----
Clintex CTiClinTex CTi and DeSci — The FutureClintex CTi and DeSci both work off the idea that scientific knowledge, including clinical trial intelligence, should be accessible.2 min read·Jan 5, 2024----
Clintex CTiCTAi Beta Release ImminentWe have been working tirelessly over the previous months on the development of our groundbreaking Clintex CTAi application.2 min read·Sep 28, 2023----
Clintex CTiAustralian Regulator approves MDMA for PTSD treatmentAustralia made history on July 1, 2023, when it became the first country in the world to prescribe MDMA and psilocybin for therapeutic use…3 min read·Jul 13, 2023--1--1
Clintex CTiAI-based Clinical Trials market to grow by 600% before end of the decadeAccording to a new study from Research and Markets, the global market for AI-based clinical trial solutions for patient matching is…3 min read·Apr 3, 2023----
Clintex CTiHow AI will drive success in Clinical TrialsIt takes up to 15 years and an average total R&D expenditure of $1.5–2 billion USD to bring a single new drug to market. About half of this…3 min read·Jan 16, 2023----
Clintex CTiClinTex 2023 RoadmapOver the past few weeks we have been meeting internally to define our strategy and goals in the runup to the new year. To this end we…2 min read·Nov 28, 2022----
Clintex CTiClinTex sign Letter of Intent with LVL HealthClintex are excited to announce the signing of an agreement with LVL Health (https://lvlhealth.co.uk/) to support their CANPAIN clinical…2 min read·Oct 31, 2022----